Adrian Rabinowicz
About Adrian Rabinowicz
Adrian L. Rabinowicz is the Chief Medical Officer at Neurelis, a board-certified neurologist and neurophysiologist with extensive experience in the pharmaceutical and biotechnology sectors.
Adrian L. Rabinowicz: Chief Medical Officer
Adrian L. Rabinowicz currently holds the position of Chief Medical Officer at Neurelis, having joined the company in 2018. With more than 20 years of experience in the pharmaceutical and biotechnology sectors, he brings extensive expertise to the leadership team. His previous roles include Chief Medical Officer at Sancilio & Company and Senior Vice President of Clinical Development and Medical Affairs at Acorda Therapeutics. His professional background is distinguished by a consistent focus on clinical development and medical affairs.
Adrian L. Rabinowicz's Education and Expertise
Adrian L. Rabinowicz is a board-certified neurologist and neurophysiologist. He received his medical degree from the Universidad Del Salvador in Buenos Aires, Argentina. He completed his residency in neurology at the University of Buenos Aires, followed by a fellowship in Epilepsy and Neurophysiology at the University of Southern California, Los Angeles. His academic journey and medical training have equipped him with specialized knowledge in neurology and neurophysiology, particularly in the area of epilepsy.
Adrian L. Rabinowicz's Background in Research and Academia
Adrian L. Rabinowicz has a notable academic background, having served as both an Assistant Professor of Neurology and the Co-Director of the USC Comprehensive Epilepsy program. He is a Fellow of the American Academy of Neurology and has received several national and international awards for his research. His contributions to neurology are well-documented in over 85 peer-reviewed papers and several book chapters, making him a respected figure in the medical research community.
Adrian L. Rabinowicz's Professional Experience
Throughout his career, Adrian L. Rabinowicz has garnered extensive experience in various roles within major pharmaceutical and biotechnology companies. He spent over seven years with Bayer HealthCare Pharmaceuticals in various capacities. His leadership roles at Sancilio & Company and Acorda Therapeutics further highlight his expertise in clinical development and medical affairs. His career trajectory showcases a robust understanding of both scientific inquiry and medical administration.